Skip to main navigation Skip to search Skip to main content

King Fahd University of Petroleum & Minerals Home

Help & FAQ Link opens in a new tab

Search content at King Fahd University of Petroleum & Minerals

Home
Profiles
Research units
Projects
Research output
Prizes
Student theses

SUCCINIMIDE-BASED COPOLYMERS AND USE AS HYDRATEINHIBITORS

Ali Asrof (Inventor)

King Fahd University of Petroleum & Minerals
Interdisciplinary Research Center for Advanced Materials
Department of Chemistry

Research output: Patent

Overview

Original language	English
Patent number	KR102342913B1
State	Published - 2021

Cite this

APA
Author
BIBTEX
Harvard
Standard
RIS
Vancouver

Asrof, A. (2021). SUCCINIMIDE-BASED COPOLYMERS AND USE AS HYDRATEINHIBITORS. (Patent No. KR102342913B1).

Asrof, Ali (Inventor). / SUCCINIMIDE-BASED COPOLYMERS AND USE AS HYDRATEINHIBITORS. Patent No.: KR102342913B1.

@misc{4cbc8307070a4877ac9c3e11327e9040,

title = "SUCCINIMIDE-BASED COPOLYMERS AND USE AS HYDRATEINHIBITORS",

author = "Ali Asrof",

year = "2021",

language = "English",

type = "Patent",

note = "KR102342913B1",

}

Asrof, A, SUCCINIMIDE-BASED COPOLYMERS AND USE AS HYDRATEINHIBITORS, Patent No. KR102342913B1.

SUCCINIMIDE-BASED COPOLYMERS AND USE AS HYDRATEINHIBITORS. / Asrof, Ali (Inventor).
Patent No.: KR102342913B1.

Research output: Patent

TY - PAT

T1 - SUCCINIMIDE-BASED COPOLYMERS AND USE AS HYDRATEINHIBITORS

AU - Asrof, Ali

PY - 2021

Y1 - 2021

M3 - Patent

M1 - KR102342913B1

ER -

Asrof A, inventor. SUCCINIMIDE-BASED COPOLYMERS AND USE AS HYDRATEINHIBITORS. KR102342913B1. 2021.

Powered by Pure Link opens in a new tab, Scopus Link opens in a new tab & Elsevier Fingerprint Engine™ Link opens in a new tab

All content on this site: Copyright © 2026 King Fahd University of Petroleum & Minerals, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

Log in to Pure Link opens in a new tab

About web accessibility Link opens in a new tab

Report vulnerability Link opens in a new tab